期刊文献+

纽曼系统模式对高龄慢性乙型肝炎患者遵医行为及自我效能感的影响观察 被引量:2

原文传递
导出
摘要 目的:观察纽曼系统模式对高龄乙肝患者遵医行为及自我效能感的影响。方法:选取2016年9月~2017年12月收治的CHB患者128例,随机分为对照组和观察组,各64例。给予对照组常规治疗及干预,观察组在对照组基础上增加纽曼系统模式干预。比较干预前后两组遵医行为及一般自我效能量表(GSES)评分。结果:干预前对照组完全遵医30例(46.88%)、不完全遵医23例(35.94%)、完全不遵医11例(17.19%),观察组完全遵医27例(42.18%)、不完全遵医25例(39.06%)、完全不遵医12例(18.75%);干预后对照组完全遵医44例(68.75%)、不完全遵医14例(21.88%)、完全不遵医6例(9.38%),观察组完全遵医58例(90.63%)、不完全遵医4例(6.25%)、完全不遵医2例(3.13%)。干预后两组完全遵医比例上升(Z=6.312、33.663,P<0.05),观察组上升程度更大(Z=9.487,P<0.05)。干预前对照组GSES平均分为(14.78±3.64)分,观察组为(15.97±4.17)分;干预后对照组为(19.74±4.87)分,观察组为(26.17±4.33)分。两组较干预前GSES评分均有所提高(t=6.526、13.574,P<0.05),且观察组提高程度大于对照组(t=7.894,P<0.05)。结论:基于纽曼系统模式的干预可有效增强CHB患者遵医行为,提升患者自我效能感。
作者 娄红敏
出处 《微量元素与健康研究》 CAS 2019年第6期86-87,共2页 Studies of Trace Elements and Health
  • 相关文献

参考文献6

二级参考文献59

  • 1Zimmerman B J. Self efficacy: an essential motive to learn. Contemporary Educational Psychology, 2000,25: 82 - 91.
  • 2Bandura A. Self efficacy: toward a unifying theory of behavioral change. Psychological Review, 1977,84: 191 - 215.
  • 3Bandura A. Self efficacy: The exercise of control. New York: Freeman, 1977.
  • 4Schwarzer R, Aristi B. Optimistic self beliefs: Assessment of general perceived self efficacy in thirteen cultures. Word Psychology: 1997,3( 1 - 2): 177 - 190. Psychologia,40:1 - 13.
  • 5Schwarzer R, et al. The assessment of optimistic self beliefs: Comparison of the Chinese, Indonesian, Japanese, and Korean versions of the General Self - Efficacy Scale.Psychologia, 1997,40: 1 - 13.
  • 6Schwarzer R, Mueller J, Greenglass E (1999). Assessment of general perceived self efficacy on the internet:data collection in cyberspace. Anxiety, Stress, and Copying,12(3):145-161.
  • 7Hambleton R K, Swaminathan H. Item response theory: principles and applications,1985,157,or 16 - 22.
  • 8Mustafa Kemal C,Tuba D, Celal A, et al. Four-year study of entecavir efficacy and safety in nucleos (t)ide-naive HBeAg positive chronic hepatitis B patients[J]. Acta Clinica Croatica,2014,53(1) :31-36.
  • 9Yang SC, Lee CM, Hu TH, et al. Virological response to entecavir re- duces the risk of liver disease progression in nucleos (t) ide analogue- experienced HBV-infected patients with prior resistant mutants [ J ]. Journal of Antimicrobial Chemotherapy ,2013,68 ( 9 ) :2154-2163.
  • 10Ahn J, Lee HM, Lim JK, et al. Entecavir safety and effectiveness in a national cohort of treatment-naYve chronic hepatitis B patients in the US-the ENUMERATE study [ J 1. Alimentary Pharmacology & Thera- peutics,2015,43 ( 1 ) : 134-144.

共引文献3438

同被引文献45

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部